welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
scientific articles
Celecoxib in a 12-Year-Old Boy with Familial Adenomatous Polyposis
source: International journal of clinical pharmacology and therapeutics
year: 2010
authors: Pérez-Segura P, Bodas A, Sereno M, Martínez-Amores B, Olivera H, Díaz S, López-Asenjo J A, Puente J, Maluenda C, Díaz-Rubio E
summary/abstract:Familial Adenomatous Polyposis (FAP) is an autosomal dominant disorder characterized by colonic polyps in early adult life. Children with this disease are at risk for colonic cancer, so prophylactic colectomy is the standard treatment to prevent this complication. Chemoprevention experience with NSAIDs in children is exceptional. This case report describes our experience with Celecoxib, a COX-2 inhibitor, in a 12-year-old boy.
organization: Hospital Clínico San Carlosread more full text source
expertly curated content related to this topic
-
Celecoxib, DFMO combination improved adenoma burden in patients with familial adenomatous polyposisIn a randomized clinical chemoprevention...
-
Tucson drug startup launches gastric-cancer trialTucson-based drug startup Cancer...
-
Comparison of Proctocolectomy and Ileal Pouch-Anal Anastomosis to Colectomy and Ileorectal Anastomosis in Familial A...Prophylactic surgical options for famili...
-
Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPAThis purpose of this study is to investi...
-
Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsemen...PURPOSE: To provide recommendations on ...
-
Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis PatientsThe purpose of this registry is to colle...
-
Phenotype and Management of Patients with Familial Adenomatous Polyposis in Hong Kong: Perspective of the Hereditary...OBJECTIVES : To report on the phenotypic...